| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 03/01/14 | | 09:39:09 | 3 Jan 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/01/14 | | 15:59:38 | 2 Jan 2014 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 23/12/13 | | 15:08:11 | 23 Dec 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/12/13 | | 17:02:43 | 18 Dec 2013 | | | FDA approves ANORO ELLIPTA | GlaxoSmithKline PLC | RNS |
| 17/12/13 | | 17:50:10 | 17 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 16/12/13 | | 17:50:23 | 16 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 16/12/13 | | 07:00:04 | 16 Dec 2013 | | | GSK to increase stake in its Indian pharma. co. | GlaxoSmithKline PLC | RNS |
| 13/12/13 | | 18:11:11 | 13 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 12/12/13 | | 17:53:57 | 12 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/12/13 | | 17:07:41 | 11 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 11/12/13 | | 16:58:06 | 11 Dec 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/12/13 | | 16:56:28 | 11 Dec 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/12/13 | | 15:31:24 | 11 Dec 2013 | | | Board Committee change | GlaxoSmithKline PLC | RNS |
| 10/12/13 | | 17:16:09 | 10 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 09/12/13 | | 17:28:16 | 9 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 09/12/13 | | 15:54:10 | 9 Dec 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/12/13 | | 17:53:50 | 5 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 04/12/13 | | 17:12:20 | 4 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 03/12/13 | | 17:31:28 | 3 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 02/12/13 | | 17:03:16 | 2 Dec 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 02/12/13 | | 12:17:34 | 2 Dec 2013 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 29/11/13 | | 17:19:47 | 29 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 29/11/13 | | 12:40:11 | 29 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/11/13 | | 17:48:28 | 28 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 27/11/13 | | 17:24:28 | 27 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 25/11/13 | | 17:14:23 | 25 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 22/11/13 | | 13:43:26 | 22 Nov 2013 | | | Tivicay® (dolutegravir) - positive CHMP opinion | GlaxoSmithKline PLC | RNS |
| 20/11/13 | | 07:00:03 | 20 Nov 2013 | | | GSK completes partial sale of Aspen | GlaxoSmithKline PLC | RNS |
| 19/11/13 | | 15:21:20 | 19 Nov 2013 | | | GSK intends to divest part holding in Aspen | GlaxoSmithKline PLC | RNS |
| 18/11/13 | | 17:40:52 | 18 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 18/11/13 | | 13:16:15 | 18 Nov 2013 | | | Relvar Ellipta receives EC marketing authorisation | GlaxoSmithKline PLC | RNS |
| 15/11/13 | | 17:21:35 | 15 Nov 2013 | | | Blocklisting Interim Review | GlaxoSmithKline PLC | RNS |
| 15/11/13 | | 17:16:23 | 15 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/11/13 | | 17:10:58 | 15 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 14/11/13 | | 17:17:15 | 14 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 13/11/13 | | 17:28:42 | 13 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 12/11/13 | | 15:52:50 | 12 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/11/13 | | 15:51:22 | 12 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/11/13 | | 07:01:38 | 12 Nov 2013 | | | darapladib Phase III Study Results | GlaxoSmithKline PLC | RNS |
| 11/11/13 | | 17:06:55 | 11 Nov 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/11/13 | | 17:29:04 | 1 Nov 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 01/11/13 | | 12:46:39 | 1 Nov 2013 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 31/10/13 | | 17:17:39 | 31 Oct 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 30/10/13 | | 17:30:09 | 30 Oct 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 28/10/13 | | 17:38:44 | 28 Oct 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 28/10/13 | | 15:42:33 | 28 Oct 2013 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 25/10/13 | | 18:07:56 | 25 Oct 2013 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |